Abstract
Prevalência e impacto clínico dos transtornos alimentares sobre os pacientes bipolares Introduction
Bipolar disorder (BD) is a serious illness 1 in which patients alternate between periods of depression and mania. This disorder has a worldwide prevalence ranging from 0.6% to 1.6% in the general population, 2 and it significantly compromises the social and work lives of affected subjects.
3 BD is frequently associated with comorbidities, which are primarily anxiety disorders, alcohol and drug abuse, and dependency, as well as eating disorders (EDs). 4 In a review of studies conducted between 1982 and 2003, 5 the prevalence of EDs in BD patients (2.3% to 15%) was higher than that in the general population (0.7% to 1.8%).
Brietzke et al. 6 studied 137 women with type I BD using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Axis I Disorders (SCID-I), and a sociodemographic questionnaire, and found a 14.6% prevalence of EDs. In this study, patients with EDs had an earlier onset of BD; more depressive episodes; more comorbidities, especially with substance use and anxiety disorders; and a higher number of suicide attempts.
Also, recently, McElroy et al. 7 investigated the prevalence and clinical characteristics of 875 type I and II bipolar patients with EDs, and showed a prevalence of 14.3%. In this study, the presence of EDs in patients with BD was associated with earlier onset of mood disorder; presence of mixed episodes and rapid cycling; presence of severe mood episodes; and history of suicide attempts, obesity, and comorbidity with alcoholism and drug abuse.
Thus, to the best of our knowledge, only few studies have explored the prevalence of EDs in BD patients, investigated the consequences of this comorbidity on quality of life, and described the characteristics of BD patients with and without EDs. Therefore, the present study aimed to assess whether several demographic and clinical variables were associated with the presence of EDs in BD patients, and to study the impact of EDs on the severity of bipolar disorder patients in a selected Brazilian sample.
Methods
All patients diagnosed with BD and who had undergone treatment between March 31, 2005, and March 22, 2009, at two university hospitals in Salvador and Porto Alegre, Brazil, were included All patients were 18 years of age or older and presented with mood symptoms of varying severity (in acute phase or not). Patients with mental disturbances who were unable to understand the study and those who refused to sign the informed consent form were excluded.
Subjects were submitted to the following assessments: clinical and sociodemographic questionnaire, Structured Clinical Interview for DSM-IV Axis I (SCID-I), Young Mania Rating Scale (YMRS), Hamilton Depression Rating Scale (HAM-D-17), Hamilton Anxiety Rating Scale (HAM-A), Global Assessment of Functioning (GAF), and Clinical Global Impression Scale (CGI). The World Health Organization Rating Scale for quality of life evaluation (WHOQOL-BREF) was used in a subsample (n = 180) of participants. The interviews were conducted by researchers who had formal training and extensive experience in dealing with all instruments.
The Statistical Package for Social Sciences (SPSS) software, version 13.0, was used for statistical analyses. Mean and standard deviations were estimated for continuous variables. For categorical variables, either Pearson's chi-square test or Fisher's exact test were used, and the Mann-Whitney U test was applied for continuous variables. Binary logistic regression analyses were conducted to assess the contribution of each predictor variable independently, and those with p < 0.10 were included in the equation. A significance level of 0.05 was used for all statistical analyses.
Results
A total of 406 bipolar patients were initially selected. Fifty (12.3%) patients were excluded due to data loss. A total of 356 (87.7%) patients were assessed.
Among the 356 bipolar patients included in this study, 5.3% (n = 19) had an ED diagnosis, current or lifetime. Of these, 57.9% (n = 11) had bulimia nervosa (BN) and 42.1% (n = 8) had anorexia nervosa (AN). The mean age of our sample was 41.4 years. There were significant differences among BD patients with and without EDs, and EDs group had a higher number of females. The only male participant met the diagnostic criteria for BN.
No significant differences were found in the CGI, GAF, HAM-A, and YMRS scores between subjects with and without EDs. There was a trend for patients with EDs to present higher HAM-A scores (p = 0.07), and HAM-D-17 scores were higher in patients with EDs compared to those without EDs (p = 0.01, Table 1 ).
In the logistic regression conducted to assess if demographic and clinical variables significantly predicted whether participants had or not EDs, 57 of the 406 participants had missing data and were not considered in the analysis. Variables whose significance was p < 0.10 [gender (p = 0.02), ethnicity (p = 0.06), marital status (p = 0.08), HAM-D (0.06), and number of comorbidities (p < 0.001)] were included in the equation. In this analysis, only gender and number of comorbidities were individually significant regarding EDs. Nevertheless, the overall model was significant when all five independent variables were included (χ 2 = 38.71, df = 5, n = 349, p < 0.001). Taken together, gender (OR = 0.61, p = 0.02), marital status (OR = 0.50, p = 0.03), and number of comorbidities (OR = 1.68, p < 0.001) were significant predictors, but not ethnicity (OR = 0.33, p = 0.13) and HAM-D (OR = 0.99, p = 0.79). These odds ratios suggest that the odds of having EDs are increasingly greater as the number of comorbidities increases and as the number of male and participants having partners decreases.
A subsample of BD patients in this study provided quality of life information by completing the WHOQOL-BREF (n = 180). Of these, only 14 had EDs. We replicated the same analysis with this smaller sample and included the psychological domain of the WHOQOL-BREF, the only quality of life domain independently significant 
Discussion
The present study found a prevalence of EDs in BD patients that is similar to that commonly seen in the literature, 8 which is higher than that found in the general population. 5 Our results also corroborate data in the literature that indicate a higher prevalence of female patients with EDs.
9,10
Also, these BD patients with comorbid EDs had significantly more negative clinical outcomes, namely higher scores for depressive symptoms as assessed by the HAM-D scale, lower scores of quality of life in the psychological domain of the WHOQOL-BREF, and significantly more psychiatric comorbidities.
EDs have been suggested to occur more frequently in the depressive phase, 11 and this phenomenon was corroborated by our study. This finding may explain, at least partially, why quality of life is impaired in these individuals, as QOL scores are likely to be markedly lower in BD patients during the depressive phase.
12 Both HAM-D and the psychological domain of the WHOQOL-BREF were significant predictors of the ED presence in BD patients when adjusted by the logistical regression model.
It is worth noting that mood stabilizers, which are the first-line treatments of BD patients, lead to weight gain.
11
This effect, by itself, could negatively impact prognosis because it reduces treatment adherence in subjects who already have an ED. 13 These patients, therefore, require individualized treatment administered by a multiprofessional and well-trained staff.
14 Our findings should be interpreted in light of several limitations. First, the cross-sectional design used herein precluded the opportunity to examine a temporal relationship between BD and ED. Second, this study used a selected sample of patients from specialised services; therefore, the results may not be generalised to other psychiatric settings or to community situations. Third, body mass index (BMI) values, which are important information for the appropriate analysis of patients with EDs, were not measured. Fourth, binge eating disorder, although widely studied, was not included in this study because it was not included as a diagnostic category by the DSM-IV. Finally, this study included only adults and all types of bipolar patients, suggesting that further studies should be conducted so that more information can be gathered to differentiate bipolar children and adolescents with comorbid EDs from the adult population. In addition, future studies should investigate the impact of EDs in different types of BDs, controlling for different variables.
In summary, this study reports the analysis of a sample of BD patients from two Brazilian large cities, confirming previous clinical findings of the comorbid current and lifetime prevalence of EDs in BD subjects seen in literature. In addition, individuals with BD and EDs presented with significantly more severe BD symptoms than those without EDs. These findings suggest the need for differential diagnostic assessments, as well as individualised treatment plans.
Our study encourages further research to elucidate the genetic and neurobiological bases of BD and EDs. Moreover, prospective studies should be encouraged to better clarify the temporal relationship and the prognostic implications of comorbid EDs in BD patients.
Conclusions
Our findings suggest that BD patients with comorbid EDs experience higher illness severity relative to BD patients without EDs. Such findings suggest the need for differentiated diagnoses and treatment plans for these patients. However, further research is needed to confirm these results and ensure that these findings can be generalised for the entire clinical population of patients with BD.
